Veer Bhavnagri
2021
In 2021, Veer Bhavnagri earned a total compensation of $3.2M as General Counsel at Allogene Therapeutics, a 32% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $176,320 |
|---|---|
| Option Awards | $1,753,120 |
| Salary | $464,000 |
| Stock Awards | $749,984 |
| Other | $13,050 |
| Total | $3,156,474 |
Bhavnagri received $1.8M in option awards, accounting for 56% of the total pay in 2021.
Bhavnagri also received $176.3K in non-equity incentive plan, $464K in salary, $750K in stock awards and $13.1K in other compensation.
Rankings
In 2021, Veer Bhavnagri's compensation ranked 4,241st out of 12,415 executives tracked by ExecPay. In other words, Bhavnagri earned more than 65.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,241 out of 12,415 | 66th |
Division Manufacturing | 1,749 out of 5,505 | 68th |
Major group Chemicals And Allied Products | 730 out of 2,375 | 69th |
Industry group Drugs | 652 out of 2,096 | 69th |
Industry Biological Products, Except Diagnostic Substances | 168 out of 449 | 63rd |
Source: SEC filing on April 26, 2022.
Bhavnagri's colleagues
We found four more compensation records of executives who worked with Veer Bhavnagri at Allogene Therapeutics in 2021.